However, some studies have shown that ApoB/ApoA-I is a better indicator of cholesterol balance than traditional lipid markers, especially in predicting the risk of ischemic events such as coronary heart disease, myocardial infarction, and ischemic stroke (15–17). This evidence concerns the gene APOB and coronary artery disorder.